Studies on fibrinolytic agent-platelet interaction
Mishina, Y.; Watada, M.
Nihon Ketsueki Gakkai Zasshi Journal of Japan Haematological Society 37(2): 154-160
1974
ISSN/ISBN: 0001-5806 PMID: 4277931 Document Number: 80829
Document emailed within 1 workday
Related Documents
Reed, G.L.; Matsueda, G.R.; Haber, E.; Haber, E. 1992: Platelet factor XIIi increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin Thrombosis and Haemostasis 68(3): 315-320Knudsen, F.; Kristensen, S.D.; Nielsen, A.H.; Ring, T.; Stoffersen, E. 1985: Decreased platelet sensitivity to prostacyclin during hemodialysis: an effect of platelet/heparin interaction? Clinical Nephrology 23(2): 107
Miyamoto, S.; Kowalska, M.A.; Marcinkiewicz, C.; Marcinkiewicz, M.M.; Mosser, D.; Edmunds, L.H.; Niewiarowski, S. 1998: Interaction of leukocytes with platelet microparticles derived from outdated platelet concentrates Thrombosis and Haemostasis 80(6): 982-988
Deguchi, K.; Deguchi, A.; Iwasaki, E.; Shirakawa, S. 1989: Effect of platelet on fibrinolytic activation Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 81: 28-33
Milligan, K.S. 1987: Tissue-type plasminogen activator: a new fibrinolytic agent Heart and Lung: the Journal of Critical Care 16(1): 69-74
Mihara, H. 1991: Fibrinolytic enzymes extracted from the earthworm. Lumbricus rubellus: a possible thrombolytic agent Nihon Seirigaku Zasshi. Journal of the Physiological Society of Japan 53(7): 231-243
Sharma, S.C.; Saini, J.S. 1981: Platelet adhesiveness, plasma fibrinogen and fibrinolytic activity in hypertension Journal of the Association of Physicians of India 29(5): 359-363
Drabant, S.; Klebovich, I.; Gachályi, B.; Renczes, G.; Farsang, C. 1998: Role of food interaction pharmacokinetic studies in drug development. Food interaction studies of theophylline and nifedipine retard and buspirone tablets Acta Pharmaceutica Hungarica 68(5): 294-306
Hofmann, B.; Meisgeier, U.; Kertscher, P.; Ostermann, G. 1988: Effects of synthetic analogues of platelet-activating factor (PAF) on fibrinolytic activity in the rat Biomedica Biochimica Acta 47(10-11): S161-S164
Perutelli, P.; Marchese, P.; Mori, P.G. 1992: Monoclonal antibody-induced platelet aggregation does not require interaction between antibody and platelet Fc receptor Haematologica 77(2): 186-187
Yoshida, Y.; Handa, H.; Hayashi, T.; Amo, M.; Aoki, M.; Kusuno, K.; Lee, E.; Uno, T. 1979: An experimental study on intrathecal injection of fibrinolytic agent for angiospasm following subarachnoid hemorrhage in the dogs Nihon Geka Hokan. Archiv für Japanische Chirurgie 48(2): 188-196
Nishimatsu, T.; Shibasaki, T.; Sasaki, H.; Nukui, H.; Kawafuchi, J.; Okada, K. 1980: Rapid measurement of fibrinolytic activity in CSF by t-AMCA score method. Correlation with concentration of antifibrinolytic agent in CSF Rinsho Byori. Japanese Journal of Clinical Pathology 28(3): 265-270
Chiang, T.M.; Mainardi, C.L.; Seyer, J.M.; Kang, A.H. 1980: Collagen-platelet interaction. Type V(A-B) collagen induced platelet aggregation Journal of Laboratory and Clinical Medicine 95(1): 99-107
Falcon, C.; Arnout, J.; Vermylen, J. 1989: Platelet aggregation in whole blood--studies with a platelet counting technique--methodological aspects and some applications Thrombosis and Haemostasis 61(3): 423-428
Fornitz, G.G. 2002: Platelet function and fibrinolytic activity in borderline and mild hypertension. the influence of age, exercise, smoking and antihypertensive therapy Danish Medical Bulletin 49(3): 210-226
Korbut, R.; Zmuda, A.; Basista, M.; Gryglewski, R.J. 1986: Eicosanoid balance at early stages of experimental atherosclerosis. its relationship with plasma fibrinolytic activity and platelet aggregation Agents and Actions. Supplements 20: 225-236
Gultekin, M.; Diribaş, K.; Buru, E.; Gökçeoğlu, M.A. 2009: Role of a non-hormonal oral anti-fibrinolytic hemostatic agent (tranexamic acid) for management of patients with dysfunctional uterine bleeding Clinical and Experimental Obstetrics and Gynecology 36(3): 163-165
Winther, K.; Gleerup, G.; Hedner, T. 1992: Enhanced risk of thromboembolic disease in hypertension from platelet hyperfunction and decreased fibrinolytic activity: has antihypertensive therapy any influence? Journal of Cardiovascular Pharmacology 19(Suppl 3): S21-S24
El-Fiky, S.M.; Fahmy, T.Y.; Ameen, A.M. 1971: Morpho-topochemical studies of Golgi apparatus and Vitamin C in normal mammary gland cells of agent free C3Hf and agent carrying the MTV in C3H mouse strain Acta Histochemica 41(1): 131-136
Matsuda, T. 1987: Monitoring of the action of anti-platelet agent Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 71: 235-240